No Data
No Data
Berenberg Bank Maintains Qiagen NV(QGEN.US) With Buy Rating, Cuts Target Price to $50.23
Top Gap Ups and Downs on Wednesday: ADI, ANET, PHG and More
This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Qiagen, Bio-Techne Downgraded at Baird Amid NIH Funding Concerns
Jefferies Maintains Qiagen NV(QGEN.US) With Buy Rating, Cuts Target Price to $52
Baird Downgrades Qiagen NV(QGEN.US) to Hold Rating, Cuts Target Price to $42